The US Food and Drug Administration (FDA) “is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat is marketed in the United States as a prescription product, Xenical, and as an over-the-counter (OTC) product, Alli.”
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.